The price sits 84.9% of the way up its 52-week range.

Price is the close for 3 Sep 2026, sourced from Yahoo Finance and checked against the 52-week range before publishing. Delayed and for research only — not investment advice.

Price chart

Which ETFs hold NVS?

Novartis appears in 2 of the funds we track, with its heaviest allocation at 14.80% in EWL.

What this means for your portfolio

If you hold more than one of the funds listed above, your exposure to Novartis is the sum of its weight in each — not the weight shown on any single fund page. This is how investors end up far more concentrated in a handful of companies than they intended, particularly when a broad market fund and a sector or thematic fund are held side by side.

Across the 2 funds holding it, the average published weight is 14.50%.

Other healthcare holdings

Community

NVS discussion

Questions on fair value, cost, dividends and risk — answered with the fund data on this page.

How should you assess the fair value of NVS (Novartis AG)?

Fair value 2 answers ETFWinner Research

Which ETFs hold NVS, and how much exposure do you already have?

Holdings 2 answers ETFWinner Research

NVS stock forecast 2026: what the data does and does not tell you

Price outlook 2 answers ETFWinner Research

Ask a question about NVS

Questions are reviewed before publishing. Please do not ask for personal investment advice — we cannot provide it.

Website

Your question More detail (optional) Your name Post question